| Drug policy and the public good T Babor Oxford University Press, USA, 2010 | 600 | 2010 |
| Cannabis policy: moving beyond stalemate R Room, B Fischer, W Hall, P Reuter, S Lenton Oxford University Press, USA, 2010 | 473 | 2010 |
| Lower-risk cannabis use guidelines: a comprehensive update of evidence and recommendations B Fischer, C Russell, P Sabioni, W Van Den Brink, B Le Foll, W Hall, ... American journal of public health 107 (8), e1-e12, 2017 | 447 | 2017 |
| Management of opioid use disorders: a national clinical practice guideline J Bruneau, K Ahamad, MÈ Goyer, G Poulin, P Selby, B Fischer, TC Wild, ... Cmaj 190 (9), E247-E257, 2018 | 421 | 2018 |
| The costs of substance abuse in Canada 2002 J Rehm, D Baliunas, S Brochu, B Fischer, W Gnam, J Patra, S Popova, ... Canadian Centre on Substance Abuse, 2006 | 408 | 2006 |
| Drug policy and the public good: evidence for effective interventions J Strang, T Babor, J Caulkins, B Fischer, D Foxcroft, K Humphreys The Lancet 379 (9810), 71-83, 2012 | 353 | 2012 |
| Routes of administration for cannabis use–basic prevalence and related health outcomes: A scoping review and synthesis C Russell, S Rueda, R Room, M Tyndall, B Fischer International Journal of Drug Policy 52, 87-96, 2018 | 301 | 2018 |
| The effectiveness of compulsory drug treatment: a systematic review D Werb, A Kamarulzaman, MC Meacham, C Rafful, B Fischer, ... International Journal of Drug Policy 28, 1-9, 2016 | 281 | 2016 |
| Prescription opioid related misuse, harms, diversion and interventions in Canada: a review B Fischer, E Argento Pain physician 15 (3S), ES191, 2012 | 251 | 2012 |
| Barriers associated with the treatment of hepatitis C virus infection among illicit drug users J Grebely, KA Genoway, JD Raffa, G Dhadwal, T Rajan, G Showler, ... Drug and alcohol dependence 93 (1-2), 141-147, 2008 | 242 | 2008 |
| Low uptake of treatment for hepatitis C virus infection in a large community‐based study of inner city residents J Grebely, JD Raffa, C Lai, M Krajden, T Kerr, B Fischer, MW Tyndall Journal of viral hepatitis 16 (5), 352-358, 2009 | 217 | 2009 |
| The costs of alcohol, illegal drugs, and tobacco in Canada, 2002 J Rehm, W Gnam, S Popova, D Baliunas, S Brochu, B Fischer, J Patra, ... Journal of studies on alcohol and drugs 68 (6), 886-895, 2007 | 215 | 2007 |
| Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study) B Fischer, J Rehm, S Brissette, S Brochu, J Bruneau, N El-Guebaly, ... Journal of Urban Health 82, 250-266, 2005 | 209 | 2005 |
| Non‐medical use of prescription opioids and prescription opioid‐related harms: why so markedly higher in N orth A merica compared to the rest of the world? B Fischer, A Keates, G Bühringer, J Reimer, J Rehm Addiction 109 (2), 177-181, 2014 | 203 | 2014 |
| Drug use, risk and urban order: examining supervised injection sites (SISs) as ‘governmentality’ B Fischer, S Turnbull, B Poland, E Haydon International Journal of Drug Policy 15 (5-6), 357-365, 2004 | 187 | 2004 |
| Changes in illicit opioid use across Canada B Fischer, J Rehm, J Patra, MF Cruz Cmaj 175 (11), 1385-1385, 2006 | 179 | 2006 |
| Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs K DeBeck, T Kerr, K Li, B Fischer, J Buxton, J Montaner, E Wood Cmaj 181 (9), 585-589, 2009 | 166 | 2009 |
| Health outcomes associated with crack-cocaine use: systematic review and meta-analyses AJ Butler, J Rehm, B Fischer Drug and Alcohol Dependence 180, 401-416, 2017 | 152 | 2017 |
| Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics B Fischer, E Oviedo-Joekes, P Blanken, C Haasen, J Rehm, ... Journal of Urban Health 84, 552-562, 2007 | 152 | 2007 |
| Heroin‐assisted treatment as a response to the public health problem of opiate dependence B Fischer, J Rehm, M Kirst, M Casas, W Hall, M Krausz, N Metrebian, ... The European Journal of Public Health 12 (3), 228-234, 2002 | 145 | 2002 |
